Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMS 2022 | Insights into the mechanisms leading to progression from MGUS and SMM to multiple myeloma

Annie Cowan • 26 Aug 2022
IMS 2022
Multiple Myeloma Rare Diseases Smoldering Myeloma

Annie Cowan, BA, Dana-Farber Cancer Institute, Boston, MA, discusses the biology of multiple myeloma precursor conditions and shares insights into how these may progress to active myeloma, commenting on the role of cellular dysregulation and cytogenetic abnormalities. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Annie Cowan

3:24
An update on the PANGEA model
Annie Cowan • 26 Aug 2022
0:50
Recent updates from the PROMISE study
Annie Cowan • 26 Aug 2022
1:35
An insight into MGIP and its role in the development of precursor conditions
Annie Cowan • 10 Apr 2022
5:04
The PANGEA model: improving risk stratification in multiple myeloma
Annie Cowan • 10 Apr 2022

Related Videos

0:59
Looking forward to COMy 2024: celebrating 10 years
Mohamad Mohty • 17 Apr 2024
0:57
Overcoming barriers to treating older patients with myeloma
Sergio Giralt • 16 Apr 2024
1:01
The potentially curative role of CAR-T therapy in myeloma
Sergio Giralt • 16 Apr 2024
1:45
Expanded approval of cilta-cel in myeloma: the value of bringing CAR-T cells into earlier lines
Monika Engelhardt • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals